B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

RBCK1

MOLECULAR TARGET

RANBP2-type and C3HC4-type zinc finger containing 1

UniProt: Q9BYM8NCBI Gene: 106161 compounds

RBCK1 (RANBP2-type and C3HC4-type zinc finger containing 1) is targeted by 1 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting RBCK1

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1Gliotoxin0.691

About RBCK1 as a Drug Target

RBCK1 (RANBP2-type and C3HC4-type zinc finger containing 1) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 1 compounds with documented RBCK1 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

RBCK1 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.